Wěi Li
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.1%
Papers in
-
- Cancer therapeutics and mechanisms 58
- Oncology 280
- HER2/EGFR in Cancer Research 57
- Cancer-related Molecular Pathways 40
- Co-authors
- Duane D. Miller (99 shared papers)Andrzej Słomiński (66 shared papers)Robert C. Tuckey (52 shared papers)Chunlei Liu (14 shared papers)Tae‐Kang Kim (39 shared papers)Jianjun Chen (19 shared papers)Bing Wu (5 shared papers)Yan Lü (20 shared papers)
- Journals
- Journal of Clinical Oncology (36 papers)Journal of Medicinal Chemistry (24 papers)Cancer Research (22 papers)PLoS ONE (20 papers)Frontiers in Oncology (18 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wěi Li
1.4k papers receiving 45.3k citations
Wěi Li's Hit Papers
Peers
Comparison fields: 5 of 206
- Cancer Research 5.7k
- Oncology 8.3k
- Pathology and Forensic Medicine 4.2k
- Molecular Biology 16.7k
- Pulmonary and Respiratory Medicine 5.2k
Countries citing papers authored by Wěi Li
This map shows the geographic impact of Wěi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wěi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wěi Li more than expected).
Fields of papers citing papers by Wěi Li
This network shows the impact of papers produced by Wěi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wěi Li. The network helps show where Wěi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wěi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.4k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Hit paper breakdown → | 2017 | 2221 |
| 2 | Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial Hit paper breakdown → | 2014 | 1589 |
| 3 | HIF-1α pathway: role, regulation and intervention for cancer therapy Hit paper breakdown → | 2015 | 1493 |
| 4 | An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site Hit paper breakdown → | 2012 | 634 |
| 5 | Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition Hit paper breakdown → | 2011 | 513 |
| 6 | 2015 | 385 | |
| 7 | 2009 | 369 | |
| 8 | 2009 | 329 | |
| 9 | Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2015 | 325 |
| 10 | Steroidogenesis in the skin: Implications for local immune functions Hit paper breakdown → | 2013 | 295 |
| 11 | 2010 | 267 | |
| 12 | 2019 | 265 | |
| 13 | 2009 | 259 | |
| 14 | 2014 | 258 | |
| 15 | 2019 | 253 | |
| 16 | 2001 | 249 | |
| 17 | 2012 | 247 | |
| 18 | 2014 | 245 | |
| 19 | 2015 | 213 | |
| 20 | 2013 | 210 |
About Wěi Li
Wěi Li is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Organic Chemistry, having authored 1.4k papers that have together received 45.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (63 papers), Synthesis and biological activity (61 papers), Cancer therapeutics and mechanisms (58 papers), HER2/EGFR in Cancer Research (57 papers), Vitamin D Research Studies (51 papers), Estrogen and related hormone effects (50 papers), Click Chemistry and Applications (46 papers) and Cancer-related Molecular Pathways (40 papers). The work is most often cited by research in Cancer Research (5.7k citations), Oncology (8.3k citations), Pathology and Forensic Medicine (4.2k citations), Molecular Biology (16.7k citations) and Pulmonary and Respiratory Medicine (5.2k citations). Wěi Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Duane D. Miller, Andrzej Słomiński, Robert C. Tuckey, Chunlei Liu, Tae‐Kang Kim, Jianjun Chen, Bing Wu, Yan Lü, Zorica Janjetović and Jin Wang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, Cancer Research, PLoS ONE and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.